Reading Time: 3 minutesThis blog is part of the ‘Highlights from Glasgow’ collection of articles, where you can read about the content of some of the talks and
Tag: NP001
Reading Time: 4 minutesAt this time of year, it’s always good to look back on the previous year to see just how far we’ve really come. We’re pleased
Reading Time: 3 minutesA very much ‘must report on’ session of the 23rd International Symposium on ALS/MND was the clinical trials and trial design session. There are many
Reading Time: 3 minutesPromising results from a Phase II clinical trial for a drug called NP001 have been announced by the biopharmaceutical company Neuraltus. The trial, conducted in America, suggested
Reading Time: 3 minutes“After a time where patients and sponsors of trials alike had become disheartened about the lack of positive clinical trials, it is exciting to see
Reading Time: 9 minutesI’m sure many of you who follow our blog have also been following the discussion on our forum about the Neuraltus trial for a drug called NP001.